TipRanks
Nuo Therapeutics (AURX)
OTHER OTC:AURX
US Market
AURX
Nuo Therapeutics
RESEARCH TOOLSreports
Want to see AURX full AI Analyst Report?

Nuo Therapeutics (AURX) Income Statement

12 Followers

Nuo Therapeutics Income Statement

Last quarter (Q2 2026), Nuo Therapeutics's total revenue was $1.77M, an increase of 152.64% from the same quarter last year. In Q2, Nuo Therapeutics's net income was $-277.60K. See Nuo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 3.31M$ 1.37M$ 608.52K$ 112.25K$ 0.00
Gross Profit
$ 2.22M$ 1.06M$ 482.43K$ 93.04K$ 0.00
Operating Expenses
$ 4.73M$ 3.52M$ 3.65M$ 3.41M$ 90.67K
Depreciation and Amortization
$ 156.94K$ 96.27K$ 105.26K$ 74.08K$ 90.67K
EBITDA
$ -2.36M$ -2.36M$ -3.06M$ -3.10M$ -90.67K
Operating Income
$ -2.52M$ -2.46M$ -3.17M$ -3.32M$ -90.67K
Other Income/Expenses
$ 4.43K$ 134.13K$ -3.16K$ 148.86K$ 0.00
Pretax Income
$ -2.51M$ -2.32M$ -3.17M$ -3.17M$ -90.67K
Net Income
$ -2.51M$ -2.32M$ -3.17M$ -3.03M$ -90.67K
Per Share Metrics
Basic EPS
$ -0.05$ -0.05$ -0.08$ -0.08$ >-0.01
Diluted EPS
$ -0.05$ -0.05$ -0.08$ -0.08$ >-0.01
Weighted Average Shares Outstanding
 47.31M 45.42M 42.08M 40.00M 30.30M
Weighted Average Shares Outstanding (Diluted)
 47.31M 45.42M 42.08M 40.00M 30.30M
Currency in USD

Nuo Therapeutics Earnings and Revenue History